Extreme Hepatic Surgery and Other Strategies : Increasing Resectability in Colorectal Liver Metastases

個数:

Extreme Hepatic Surgery and Other Strategies : Increasing Resectability in Colorectal Liver Metastases

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 383 p.
  • 言語 ENG
  • 商品コード 9783319791920
  • DDC分類 616.35

Full Description

This book describes the diagnoses; staging and management of patients with colorectal liver metastases initially considered unresectable and portrays the different strategies to increase resectability along with their tactics and tricks. Colorectal carcinoma is the third most commonly diagnosed cancer in the world and according to recent cancer statistics around 1.23 million patients are diagnosed each year. Of these patients, approximately 50% will develop liver metastases during the course of their disease and around 15-25% are found to have stage IV disease at diagnosis. Liver resection has been recognized as the treatment of choice for these patients, offering overall 5-year survival rates of up to 50-60% and the only hope for cure. However, at diagnosis only 10-20% of these patients are possibly amenable to surgical resection with curative intent. The possibility to achieve an R0 resection is many times limited by the amount and quality of the future liver remnant (FLR), being posthepatectomy liver failure (PHLF) the most feared and severe complication after major liver resections. With the years, diverse strategies have been developed with the intention to increase resectability by increasing the future liver remnant and/or reducing tumor size, e.g. ALPPS. Along with these techniques, associated surgeries are developed including multivisceral resections, which broadens even more the resectability for patients.

Contents

Part I Introduction. 1. Introduction.- 2. Liver surgical anatomy.- II. Global patient evaluation and oncological assessment.- 3. Resectability assessment with diagnostic imaging.- 4. Liver function evaluation before extreme liver surgery.- 5. Imaging-based preoperative planning.- 6. Choosing the best strategy. Multidisciplinary evaluation.- III.- Non-operative multimodal therapies.- 7. Conversion and neoadjuvant therapies.- 8. Portal embolization.- 9. Intraarterial chemotherapy.- 10.  Radioembolization.- IV. Surgical strategies.- 11. Anesthetics management.- 12. Intraoperative evaluation of resectability.- 13. Vascular control in major hepatic resections.- 14. Two-stage liver surgery.- 15. Two-stage liver surgery with portal occlusion.- 16 ALPPS.- 17. Parenchymal-sparing liver resections.- 18. Combined vascular resections.- 19. Ex-vivo liver surgery.- 20. Liver transplant.- 21. The roll of laparoscopy in advanced liver disease.- V. Management of concomitant extrahepatic disease

.- 22. Pulmonary metastases.- 23. Nodal involvement.- 24. Peritoneal disease.- 25. Adjacent organs invasion. Multivisceral resections.- VI. Postoperative complications and their management.- 26. Complications of hepatic resections.- VII. Palliative care.- 27. Palliative care in patients with extensive disease.



 

最近チェックした商品